Pharma

Taking stock of the drug industry, from the lab to the medicine chest

Pharmalot

Pharmalittle: FDA to speed review of controversial dengue vaccine; Allergan disappoints investors

By Ed Silverman

An image of Ian Read.
Pharmalot

Hold on to your wallet: Pfizer CEO says pricing will be ‘business as normal’ in January

By Ed Silverman

Pharmalot

Former Valeant and Philidor executives are sentenced to one year in prison

By Ed Silverman

A photo of Hydrocodone Acetaminophen.
Pharmalot

Rite Aid shareholders vote to support increased oversight of opioid sales

By Ed Silverman

Pharmalot

Former Genentech employees are arrested on charges they stole trade secrets

By Ed Silverman

Pharmalot

Pharmalittle: Utah insurer sends folks to Mexico for drugs; Democrats gear up to take on pharma

By Ed Silverman

Doctor patient conversations
Pharmalot

Financial conflicts of interest in clinical practice guidelines remain an ‘intractable problem’

By Ed Silverman

Pharmalot

J&J loses patent fight over key prostate cancer drug, teeing up generic competition

By Ed Silverman

Biotech

Dicerna strikes another licensing deal to develop RNAi-based drugs

By Jonathan Saltzman — Boston Globe

Pharmalot

AbbVie and Abbott pay $25 million to resolve claims of illegally marketing a cholesterol pill

By Ed Silverman

Pharmalot

Pharmalittle: Will a small biotech upend the cholesterol market? J&J loses patent protection on key drug

By Ed Silverman

Light micrograph of a fatty liver
Pharma

Pfizer, Novartis pair up on fatty liver drug trials as rivals near finish line

By Adam Feuerstein

Hires
Pharmalot

Up and down the ladder: The latest comings and goings

By Ed Silverman

Pharmalot

Pharmalittle: Will West Virginia and McKesson settle an opioid lawsuit? Trump drug price plan sparks controversy

By Ed Silverman

Piglets
Pharmalot

European Parliament passes law to restrict antibiotic use in food-producing livestock

By Ed Silverman

Pharmalot

Pharmalittle: Trump to give speech today on drug pricing; FDA approves a novel, but pricey flu drug

By Ed Silverman

Cholesterol Drugs
Pharmalot

Amgen lowers wholesale price for its cholesterol medicine in bid to remain competitive

By Ed Silverman

Flu shot doses
Pharmalot

Confidence in vaccines is declining in Europe and creates concerns about disease outbreaks

By Ed Silverman

Pharmalot

Pharmalittle: West Virginia AG denies an opioid deal with McKesson is coming; McCaskill bets on drug pricing

By Ed Silverman

Civica Rx
Politics

U.S. regulators offer a helping hand to new nonprofit drug company

By Nicholas Florko

Clinical Trial pricing
Pharmalot

Here’s a hypothesis: Lower doses of some cancer pills could save a lot of money

By Ed Silverman

Fog
Pharmalot

Pharma is getting away with lots of patent ‘evergreening’ in India

By Ed Silverman

Biotech

Pfizer, Bain launch a startup to focus on nervous system diseases

By Jonathan Saltzman — Boston Globe

Pharmalot

Pharmalittle: D.C. law firms prep pharma for a Democratic house; Allergan loses another battle over Restasis patent deal

By Ed Silverman

Pharmalot

Mallinckrodt will be honored for research into a drug that causes sticker shock

By Ed Silverman

Pharmalot

Pharmalittle: Pharma ‘war games’ for a Trump-Democrat alliance on drug prices; Arizona ends vaccine education program

By Ed Silverman

Merck
Pharma

Is ‘STING’ a new and promising cancer target? Don’t look at Merck’s study results for a definitive answer

By Adam Feuerstein

Pharmalot

Maryland attorney general asks Supreme Court to uphold generic price gouging law

By Ed Silverman

Cancer Drugs
Pharmalot

Some European countries decide to cover cancer drugs much faster than others

By Ed Silverman

Sign up for our Daily Recap newsletter

A roundup of STAT’s top stories of the day in science and medicine

Privacy Policy